To rule out any off-target effects by GSK3β inhibitors, we directly knocked down endogenous GSK3β by infecting AN3CA cancer cells and EM-TERT control cells with lentivirus carrying shRNA against human GSK3β. Here, GSK3B is linked to cancer.